Join
Live feed
·
INSIDERFilingvia Quantisnow
Unity Biotechnology Inc. logo

SEC Form 4: Ghosh Anirvan sold $12,453 worth of shares (2,573 units at $4.84) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 92,235 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UBX (Unity Biotechnology Inc.) and more on Quantisnow.